Severe reversible cardiomyopathy in four unrelated infants associated with mitochondrial DNA D-loop heteroplasmy

Pediatric Cardiology

Volumn 24, Issue 5, 2003, Pages 484-487

  Boles, R G ^a,b   Luna, C ^a,b   Ito, M ^a,c  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiomyopathy; Control region; D loop; Heteroplasmy; Infancy; Mitochondrial DNA

Indexed keywords

CAPTOPRIL; CARNITINE; DIGOXIN; FUROSEMIDE; INOTROPIC AGENT; KETONE; LACTIC ACID; MITOCHONDRIAL DNA; UBIQUINONE;

ARTICLE; CARDIOMYOPATHY; CASE REPORT; CLINICAL FEATURE; DISEASE MARKER; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA POLYMORPHISM; ENERGY METABOLISM; FEMALE; HETEROPLASMY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; MALE; MUSCLE BIOPSY; POINT MUTATION; REMISSION;

CARDIOMYOPATHIES; CHILD, PRESCHOOL; DNA, MITOCHONDRIAL; FEMALE; HUMANS; MALE; MUTATION;

EID: 0042522654     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-002-0263-8     Document Type: Article

References (10)

1. Arbustini E, Diegoli M, Fasani R, et al. (1998) Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy. Am J Pathol 153:1501-1510
2. Bonnet D, de Lonlay P, Gautier I, et al. (1988) Efficiency of metabolic screening in childhood cardiomyopathies. Eur Heart J 19:790-793
3. DiMauro S, Hirano M (1998) Mitochondria and heart disease. Curr Opin Cordial 13:190-197
4. Friedman RA, Moak JP, Garson A (1991) Clinical course of idiopathic dilated cardiomyopathy in children. J Am Coll Cardiol 18:152-156
5. Ito M, Le ST, Chaudhari D, et al. (2001) Screening for mitochondrial DNA heteroplasmy in children at risk for mitochondrial disease. Mitochondrion 1:269-278
6. Lewis AB, Chabot M (1991) Outcome of infants and children with dilated cardiomyopathy. Am J Cardiol 68:365-369
7. MITOMAP (2001) A human mitochondrial genome database. Center for Molecular Medicine, Emory University, Atlanta, GA, USA. http://www.gen.emory.edu/mitomap.html
8. Saudubray JM, Martin D, de Lonlay P, et al. (1999) Recognition and management of fatty acid oxidation defects: a series of 107 patients. J Inherit Metab Dis 22:488-502
9. Schwartz ML, Cox GF, Lin AE, et al. (1996) Clinical approach to genetic cardiomyopathy in children. Circulation 94:2021-2038
10. Shoffner JM (2001) Oxidative phosphorylation diseases. In: Scriver CR, et al (2000) (ed) The Metabolic and Molecular Bases of Inherited Disease, 8th edn. McGraw-Hill, New York, pp 2367-2423